Supply chain issues for 2012

For pharmaceutical companies in 2012, supply chains will play a major role in their ability to adapt, consolidate or refocus their core business segments. The world will continue to throw new obstacles and challenges for moving products and materials into […]

Read More

The Battle for Control of Specialty Drugs

Third-party payers are increasingly dissatisfied with the buy-and-bill process for specialty pharmaceuticals covered under a patient’s medical benefit. In response, some pharmacy benefit managers (PBMs) are developing services that substitute a specialty pharmacy-to-provider channel for the currently dominant specialty distributor-to-provider […]

Read More

ACOs and Their Impact on Pharma

Obamacare, officially known as the Patient Protection and Affordable Care Act (PPACA) was signed into law March 23, 2010. It’s now being challenged in the Supreme Court by the Department of Justice and 26 states on constitutional grounds, namely, that […]

Read More

Fix the Drug Shortage Problem- Now

If it weren’t for the fact that patients are suffering—even dying—because of drug shortages, the issues surrounding it would make an excellent MBA project for some enterprising student. As being reported in this issue and the recent past, the number […]

Read More

Drug shortages are opening the door to price gouging

Reports from the American Hospital Association, American Society of Health-System Pharmacists, University of Michigan and the Premier healthcare alliance found that the vast majority of hospitals nationwide are experiencing life-threatening shortages of medicines needed to provide essential patient care. The […]

Read More